“Introduction of biosimilars, high prices, expiry of patents and numerous side effects of EPO will hinder the global erythropoietin market”, says RNCOS.
Noida, UP -- (SBWIRE) -- 08/24/2015 -- According to a new research report by RNCOS entitled, "Global Erythropoietin Market Outlook 2020", the US industry has been witnessing higher growth in erythropoietin backed by the government support and rising incidence of chronic diseases. The global erythropoietin market generates approximately US$ 6.5 Billion in 2014 and expected to fall at CAGR -0.5% during 2014-2020.
Introduction of inexpensive biosimilars, high prices of erythropoietin drugs, expiry of patents and number of side effects of EPO are affecting the growth of global erythropoietin market. More and more people are becoming aware of the cheap biosimilars of EPO drugs and are using them to get rid of painful chronic illness. However industry has potential to grow in long run backed by factors such as strong government support, increasing incidence of chronic illness, increasing affordability and changing lifestyle which includes smoking and consumption of excess alcohol. Companies such as Johnson & Johnson, Roche Inc. and Amgen are considered to be the dominant players in the global erythropoietin market.
The report is spread in over 40 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Global Erythropoietin Industry. The study presents transparent picture major erythropoietin drugs such as Epogen, Ararnesp, Procrit/Eprex, Mircera, NeoRecormon and others including the factors affecting their growth. The research further covers global erythropoietin industry, detailed analysis of geographical segments as well as applications of erythropoietin.
The report also covers detailed information about active market players in the Global Erythropoietin Industry, including small and large players to enable the clients understand the market structure and its growth during the forecasted period. In brief, the report, "Global Erythropoietin Market Outlook 2020", covers all the necessary aspects of the global erythropoietin industry, providing an in-depth research and prudent analysis of the key segments.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM771.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.